BNP Paribas Financial Markets’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8K | Buy |
|
|||||
|
2025
Q1 | $11.4K | Buy |
|
|||||
|
2024
Q4 | $3.59K | Sell |
|
|||||
|
2024
Q3 | $3.76K | Sell |
|
|||||
|
2024
Q2 | $3.74K | Sell |
|
|||||
|
2024
Q1 | $299K | Buy |
|
|||||
|
2023
Q4 | $228K | Buy |
|
|||||
|
2023
Q3 | $525K | Buy |
|
|||||
|
2023
Q2 | $317K | Sell |
|
|||||
|
2023
Q1 | $299K | Buy |
|
|||||
|
2022
Q4 | $142K | Sell |
|
|||||
|
2022
Q3 | $332K | Buy |
|
|||||
|
2022
Q2 | $186K | Buy |
|
|||||
|
2022
Q1 | $76.3K | Sell |
|
|||||
|
2021
Q4 | $158K | Buy |
|
|||||
|
2021
Q3 | $163K | Buy |
|
|||||
|
2021
Q2 | $29.1K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $17.3K | Buy |
|
|||||
|
2020
Q1 | $11.1K | Buy |
|
|||||
|
2019
Q4 | $14.6K | Buy |
|
|||||
|
2019
Q3 | $5.96K | Buy |
|
|||||
|
2019
Q2 | $8.75K | Sell |
|
|||||
|
2019
Q1 | $44.4K | Buy |
|
|||||
|
2018
Q4 | $67 | Sell |
|
|||||
|
2018
Q3 | $12.3K | Hold |
|
|||||
|
2018
Q2 | $16.9K | Sell |
|
|||||
|
2018
Q1 | $86.6K | Buy |
|
|||||
|
2017
Q4 | $121K | Buy |
|
|||||
|
2017
Q3 | $51.3K | Sell |
|
|||||
|
2017
Q2 | $55.9K | Buy |
|
|||||
|
2017
Q1 | $746 | Sell |
|
|||||
|
2016
Q4 | $18.5K | Sell |
|
|||||
|
2016
Q3 | $17.9K | Buy |
|
|||||
|
2016
Q2 | $6.41K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $28K | Buy |
|